Organization Profiles Site map description
H
Hiroshima UniversityHiroshima UniversityHiroshima UniversityResearch & Technology Organization from Japan
Hiroshima University, a Japanese national university corporation, is located at Higashi Hiroshima, Hiroshima Pref. , Japan, which is away about 800km west from Tokyo, facing a national park, the “Seto Inland Sea”. - History: Hiroshima University was established in 1949 through integration of existing higher educational institutions, featuring 11 faculties and 12 graduate schools. - Faculties and Graduate Schools: Faculties are classified as Science, Engineering, Applied Biological Science, Medicine, Dentistry, Pharmaceutical Sciences, Letters, Education, Law, Economics and Integrated Arts and Sciences. Graduate schools are classified as Science, Engineering, Advanced Sciences of Matter, Biosphere Science, Biomedical Sciences and Health Sciences, Letters, Education, Social Sciences, Law School, Integrated Arts and Sciences, International Development and Cooperation. The numbers of staffs are academic staffs of 1,717 and non-academic of 1,589, totaling 3,306, and those of students are undergraduate students of 10,941, graduate of 4,239 and others of 265, totaling 15,445, including international students of 994 (from 66 countries) , as of May 2013. - Research and Outreach Activities: Hiroshima University has a good reputation in the various advanced research fields, such as bio-medicine, engineering, chemistry, physics, material science, etc., yielding the international collaborative research with foreign companies and institutions ranked 7th in the Japanese universities as of FY 2012.
Hitech AnalyticsHitech AnalyticsHitech AnalyticsPublic Agency from United States
Hitech Analytics, the leading data analytics consulting company from USA, is focused on developing and delivering solutions that enable clients to leverage intelligence from huge data volumes to respond rapidly to evolving markets, customer expectations and competitors.
HomoDeaeHomoDeaeHomoDeaeSmall and Medium Enterprise from Italy
Do you have a system for continuous innovation without creating a burn out for your most valuable asset - your people? The human part of innovation in growing enterprises is often overlooked. Especially with the latest trends in tech innovation such as implanting chips into your brain hoping to become a SuperHuman. At HomoDeae we believe that the human part of innovation is relational in its nature. At its core it’s how we relate to ourselves, each other and our planet home. Our innovation is through synergistic, Stage 4 communities. We provide the unique kind of training and support mavericks need to rapidly grow the impact their teams are able to make. Our mission is by 2025 to support 1,000 of these leaders who are bridging our current world to the future. How do we do this? We train project managers in how to operate in Stage 4 (interdependence), and then how to build unstoppable, resilient, Stage 4 teams and communities that innovate to co-create better results with the same resources. Why Stage 4? Stage 4 is the natural habitat of humanity in the future. It's a space where outliers are celebrated as the heroes of humanity that they are: the courageous few that dare to defy the status quo and trust in themselves rather than the powers that be. Even these mavericks need support. And this is where we excel. We are the facilitators and gatekeepers of next level communities that are interdependent oases in a desert of conformity and judgement. Services for independent, forward-thinking leaders: High level, whatever-it-takes support to help you commence living at Stage 4, as well as to establish your own interdependent, highly effective teams to amplify your capacity to solve urgent planetary issues. ----------------------------------------------------------------------------------------------------- Want to know more? Drop me a message on LinkedIn or send me an email: bakytgul@homodeae.com- Horizon Risk Consultancy LtdHorizon Risk Consultancy LtdHorizon Risk Consultancy Ltd
Small and Medium Enterprise from United Kingdom
Based in Huddersfield, UK, Horizon Risk Consultancy Ltd provides practical and integrated health, safety and environmental risk management solutions and business improvement services that reduce the risks and improve the efficiency of your business. 
Hub APTAHub APTAHub APTATechnology Transfer Network from Chile
We are Andes Pacific Technology Access (APTA) a Chilean corporation that manages new science-based business opportunities derived from translational science. We commercialize technologies developed by our partners (universities and research centres) and identify their R&D capabilities to connect and serve international companies. To transfer high-impact technologies to multiple industries and propel science-based Start-Ups #madeinchile to the market. We aim to enhance the collaboration between the Chilean scientific community and the global innovation ecosystem, to promote the country as an innovation hotspot in Latin America.
Hub2i Tecnología, innovación y negocioHub2i Tecnología, innovación y negocio- HUBTECHUBTEC
- HydroCavitHydroCavitHydroCavitWe are a Brazilian start-up founded in early 2020, which invented, developed and produces innovative technology that uses the physical phenomenon of hydro cavitation to optimize industrial processes. Our Controlled Hydrocavitation Reactor (CHR) is capable of being inserted into existing industrial processes, leading to an almost immediate increase in their productivity.
Hyperevo LTDHyperevo LTDHyperevo LTDTechnology Transfer Network from United Kingdom
WELCOME TO THE HYPEREVO ON INNOGET. Our purpose is to combine knowledge and skills from Universities and Companies to support R&D projects and innovation. We help Technology Development Enterprises to thrive, prosper and connect themselves within the international environments and ecosystems.
I
- I.M. tecnics project management SLLI.M. tecnics project management SLL
- IAO SB RASIAO SB RASIAO SB RAS
Non-Profit Research Organization from Russian Federation · Tomsk
I have been working in the system of the Academy of Sciences since 1974. Position - Senior Researcher. Specialty in diploma - chemist. The dissertation on the topic "Separation of lithium isotopes under conditions of phase boundary formation" - specialty "chemistry of rare. scattered and radioactive elements". Over the past 10 years, published about 50 scientific papers, 13 patents and 3 books in various fields of chemistry. Registered in the federal register of experts in the scientific and technical field of the Ministry of Education and Science of the Russian Federation 
IATA-CSICIATA-CSICIATA-CSICResearch & Technology Organization from Spain
The Institute of Agrochemistry and Food Technology (IATA), created in 1966, is a center of the Spanish National Research Council (CSIC). Its scientific-technical objective is to carry out research of excellence on the production of sustainable and quality food, taking into account its safety, health impact and consumer acceptance. IATA research can be grouped into the following lines of research: INNOVATION IN FOODS AND PROCESSES Study the mechanisms responsible for the function of different food components by a multidisciplinary approach. Investigate the processes that add value and sustainability, and which determine or modulate the physico-chemical, biochemical, nutritional and sensorial behaviour of complex food matrices by placing special emphasis on products from plants (cereals and other grain based products) and animals (meat and meat based products). The sub-lines are: Structure and functionality of components in food matrices Mechanisms to develop aroma, flavour and functional ingredients Sustainability in food processes Sensorial and consumer perceptions FOOD SAFETY AND PRESERVATION Food safety is an essential requirement in a healthy food supply system that needs to be dealt with in different ways. On the one hand, food preservation as a fundamental discipline of production processes that allows food safety and quality to be guaranteed in order to constantly supply food from farms to consumers. On the other hand, studies that rapidly, sensitively and accurately detect and quantify microorganisms, residues and chemical contaminants are necessary to lower or eliminate the risk of exposure to these agents. The sub-lines are: Preservation and packaging technologies Biopolymeric materials and nanotechnology Microbiological risks Pollutants and chemical waste DIET, MICROBIOTA AND HEALTH Certain food confers the organism with benefits that go beyond their nutritional input by helping to improve general well-being or reducing risk of disease. The digestive tract is colonised by numerous microorganisms (microbiota), which have co-evolved with human beings for millions of years, and have struck a balance that is vital to maintain health. This research line features a true revolution thanks to modern molecular techniques, allowing a clear connection of health with components of diet and intestinal microbiota. This allows innovations and dietetic solutions to develop that can help prevent diseases and chronic disorders. The sub-lines are: Probiotics and prebiotics Microbiota and Microbiome Nutrients and bioactive components FOOD BIOTECHNOLOGY The Food Biotechnology line aims to understand the physiological and molecular bases of the action of organisms and molecules in food production. This knowledge is used to develop new processes that improve food quality, safety and shelf life. Research conducted in this line spans from the selection of molecules and organisms with enhanced properties for food production to the design of new foods with improved functional properties. This line includes researchers with extensive expertise in the study of microorganisms and molecules of interest for food production as well as the ripening and conservation of fruits. The sub-lines are: Yeasts Lactic acid bacteria Filamentous fungi Protein engineering Postharvest and fruit quality
IBB-UABIBB-UABIBB-UABResearch & Technology Organization from Spain
The Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB) to promote fundamental biological research. In the year 2000, the focus of research evolved towards the Biotechnology and Biomedicine fields, with the aim of advancing scientific findings into translational results. At present, the Institute hosts 18 research groups organised into 3 programmes and working in 7 areas of expertise: Bioinformatics, Cellular Biology, Structural Biology, Genomics, Immunology, Microbiology and Proteomics. This multidisciplinary character, one of the most relevant characteristics of the IBB, allows for a broad approach to biological problems, both basic and applied. The IBB is also highly engaged in academic training at the undergraduate and postgraduate levels.- IBD Consulting & Co.IBD Consulting & Co.IBD Consulting & Co.
Small and Medium Enterprise from Germany · Frankfurt am Main
-10 years experience in medical device product and market development -built-up full new business line and new industrial manufacturing site -supported implementing new technologies -lead teams up to 20 -built up own business with team of 4 
IBIMA-Plataforma BionandIBIMA-Plataforma BionandIBIMA-Plataforma BionandIBIMA is a space for multidisciplinary research in biomedicine and nanomedicine that is centered around the Regional and Virgen de la Victoria University Hospitals in Malaga, together with Primary Care, the biotechnological groups of the University of Malaga and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND).
ICL InnovationICL InnovationICL InnovationLarge Enterprise from Israel · Kiryat Ata
About ICL ICL is one of the world’s leading companies in fertilizers and bromine based chemicals. ICL produces approximately a third of the world’s bromine and a variety of bromine based products, such as flame retardants, biocides and engineered materials. About ICL Innovation ICL Innovation is the flagship initiative of ICL’s new Open Innovation program. With the goal of accelerating ICL’s development of the sustainable new products and processes needed to solve major global challenges. We've created an Innovation Incubator to enable the company to benefit from the full range of knowledge, creativity and business initiatives from around the world.
ICMAB-CSICICMAB-CSICICMAB-CSICThe Institute of Materials Science of Barcelona (ICMAB) is a Severo Ochoa Centre of Excellence research center which beongs to the Consejo Superior de Investigaciones Científicas (CSIC) and is governed by a Foundation board. The Institute was set up in 1987 and subsequently, in April 1991, the laboratories were opened at the Campus of the Autonomous University of Barcelona (UAB). It is part of the Barcelona Nanotechnology Cluster in Bellaterra. The aim of the institute is to carry out research aimed at obtaining and characterising materials of industrial interest. Its activities are based on the synthesis, preparation, crystallization and characterisation of functional high-performance materials and nanomaterials, which in some cases have led to the construction of device prototypes based on these materials. Studies and improvements both of conventional materials, as well as new molecular, supramolecular, magnetic, superconducting and porous materials etc. are being developed through projects and research contracts. There are currently 9 ERC funded projects at ICMAB. To develop these activities, at present there are 57 permanent staff among researchers and back up personnel together with 80 non-permanent staff divided into eight researgh groups, one general unit service, and one unit of Scientific and Technological Services. In 2016 the ICMAB reached the 100.000 citations, and it is currently the first centre, among the CSIC centres, in the Nature Index. Each permanent researcher publishes close to 5 articles per year in Journals with a very high impact factor.
ICN2ICN2ICN2Non-Profit Research Organization from Spain
R&D organization with a focus on Nanotechnology and Nanoscience. We have a wide patent portfolio and record of technology transfer activities, including 13 spin-offs, 4 products on the market, 20 licenses, numerous joint collaborations with companies and a high revenue in commercial activities.
IDIBELLIDIBELLIDIBELLTechnology Transfer Office from Spain
The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center established in 2004, located in L’Hospitalet de Llobregat, south of Barcelona, Spain. Its stakeholders are Bellvitge University Hospital and Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, University of Barcelona and the City of L’Hospitalet de Llobregat. IDIBELL comprises more than 1200 researchers integrated in 67 research groups strategically organized in 4 scientific areas: Cancer, Neurosciences, Translational and Regenative Medicine. The IDIBELL Core Research Facilities include a set of centralized platforms dedicated to developing and providing research resources to assist campus biomedical researchers, such as: biobank, proteomics unit, genomics unit, cytomics unit, C. elegans facility, animal facility, statistical assessment for researchers, Clinical research unit (UICEC) and biomarkers platform. Through these different resources, IDIBELL would like to supply equipment and instrumentation, technical expertise and training to promote innovative, cutting edge research. IDIBELL has the purpose of connecting academia and industry in order to promote innovative ideas to the market and therefore to society, by supporting professionals along the process.- IDIFARMAIDIFARMA
IISPVIISPVIISPVThe Institute of Health Research Pere Virgili (IISPV, in Catalan) is an umbrella organisation that coordinates all the biomedical and health research activities in Southern Catalonia. Founded in 2005, the IISPV is a collaborative venture among the hospitals in Tarragona (University Hospital Joan XXIII), Reus (University Hospital San Joan de Reus) and Tortosa (Hospital Verge de la Cinta), the University Rovira i Virgili (URV) and the Pere Mata Mental Health Institute. The IISPV vision is to act as a knowledge catalyst for a healthier future for all. A member of the CERCA Network of Excellence, the IISPV is formed by 21 Research Groups organised in 3 Strategic Areas. Our scientific community is supported by 8 Core Units that provide state-of-the-art facilities and the educational programs offered by the URV. In addition, the IISPV has strong bounds with the regional biotech and industrial network, as a member of “Tarragona Regió del Coneixement”. The IISPV aims to promote and strengthen research in health across the prosperous regions of Tarragona and Terres de l’Ebre. The geographical spread of our institutions across the region has facilitated a bottom-up approach with our research priorities. Thus, we are internationally recognised for unravelling the influence that the environment, nutrition and other socio-economic factors have in human health.- IMAGINEUIMAGINEU
IMDEA EnergyIMDEA EnergyIMDEA EnergyResearch & Technology Organization from Spain
IMDEA Energy Institute was created in 2006 as non-profit Foundation to promote and carry out R&D&i activities to contribute to the development of a sustainable and decarbonised energy system. IMDEA Energy is strongly committed to the transfer of R&D outcomes to the productive sector and to seek joint eff orts with other technology research centers and universities, promoting excellence in research on energy issues and complementarity among different entities. IMDEA Energy gathers cutting edge skills and significant experience in R&D, testing and assessment of energy technologies and offers these services to private companies, universities and research and technological centers. Research lines: - Production of sustainable fuels: hydrogen, biofuels and valorized wastes - Solar power - Energy storage: electrochemical, thermal and thermochemical systems - Energy systems with enhanced efficiency - Power systems and Demand Management - Valorization of CO2 emissions - Analysis and assessment of energy systems In 2020, it obtained the accreditation of ‘María de Maeztu’ Unit of Excellence, granted by the State Research Agency to identify and promote excellence in high-impact scientific research.
IMIM Institut Recerca Hospital del MarIMIM Institut Recerca Hospital del MarIMIM Institut Recerca Hospital del MarResearch & Technology Organization from Spain
IMIM (Hospital del Mar Medical Research Institute), located at the Barcelona Biomedical Research Park (PRBB) is, up to 82%, made up of research groups lead by professionals from the MAR Health Park , most of whom are associates of the Autonomous University of Barcelona (UAB) and the Pompeu Fabra University (UPF), as well as other seconded staff members from the Centre for Research in Environmental Epidemiology (CREAL), the Centre for Genomic Regulation (CRG), the Department of Experimental and Health Sciences of the Pompeu Fabra University (DCEXS-UPF), the Centre of Regenerative Medicine in Barcelona (CMRB) and the Barcelona Biomedical Research Park (PRBB). On 16 December 2013, the Accreditation Committee of the Carlos III Health Institute (ISCIII) approved the acreditation of IMIM as a Health Research Institute, which was ratified by the State Secretarial of Research, Development and Innovation for the Order of 17 February 2014. At IMIM there are around seven hundred professionals, of which one hundred and nineteen are lead researchers distributed in fifty-six research groups integrated into the five multi-disciplinary programmes framing research activities within IMIM: Cancer, directed by Joan Albanell Epidemiology and Public Health, directed by Jordi Alonso Cardiovascular and inflammatory processes, directed by Miguel López-Botet Biomedical Informatics, directed by Ferran Sanz Neurosciences, directed by Rafael de la Torre A large proportion of its budget is provided by external competitive funds that are managed by the Mar Institute of Medical Research Foundation. The scientific output generate from this research includes almost 550 annual papers in international journals indexed in the Science Citation Index (SCI). Another relevant fact is that 65% of the IMIM papers are published in journals that are in the top quartile of their category. IMIM has a Scientific Advisory Board (SAB) made up of a group of prestigious international expert scientists from the different areas of the IMIM research programmes.
Impuls'InnovImpuls'InnovImpuls'InnovInnovation strategy and sustainable innovation consultancy: expertise and support to structure, develop and boost your business or innovative project: -Corporate strategy: we work with our customers to co-construct their growth strategy: strategic foresight, business models, innovation governance, sustainable innovation, innovative ESG financial strategy, innovative CSR strategy, SDG, etc. -Innovation management: we create a culture of innovation: innovation marketing, diagnostics, design thinking ideation, sustainable innovation, innovation process, feasibility, market research, business model, business plan, technology scouting, international industrial partner search, co-creation, open innovation, operating licences, etc. -Scouting of innovative technologies and partners for co-creation: creation and development of international partnerships, monitoring for licensing-out, merger-acquisition, licensing-in, etc., relationship and negotiation support, etc. -Training in innovation strategy and sustainable innovation: managers and team buildings: innovation diagnostics, sustainability diagnostics, innovation culture, innovation methods, conferences and training, design thinking, innovation challenges, etc. -Financing innovation: diagnosing aid, research tax credit, young innovative companies, innovation tax credit, subsidies, European funding, EIC, etc. -Transition management and change management through innovation -Technological expertise: materials, medical devices, automotive, environment, robotics, sensors, electronics, etc.
impulseimpulseimpulseSmall and Medium Enterprise from Spain
IMPULSE is a SME that provides R&D, innovation and consulting for consumer products. R&D: Strategy and management R&D project management R&D Strategic Design Innovation Creation of concepts from products ideas, they can have different origins: Technology Consumer need Market opportunity Connecting a new technology to other businesses Selecting the right technology for a product Consultancy Consultancy in delivery systems and vaporizers
Incr-Edible IngredientsIncr-Edible IngredientsIncr-Edible IngredientsWe produce upcycled rice based ingredients to fortify protein content , shelf-life performance and texture in plant-based products. We produce: - RE-Starch: native non-sticky rice starch, native and pregelatinized - IN-Rich: New type of low-heavy metals stabilized rice bran - RE-Pro 80: Improved rice protein with more 79% protein, ultra fine and standard Who are we? - 4th generation, 100 years old family owned and operated group spin off - Long time grain and agri experts - Operating in the Netherlands since 2016 - Aim to create new ingredients providing functional and health benefits to plant based products from rice byproducts - Working towards the protein shift - Patented & patent pending production technologies - Deeply engaged in selection of rice cultivations for superior functional and health performance Manufacturer of B2B food and nutraceutical ingredients & additives. Partnership with world-class universities and research centers. Own production know-how.
